Visio-Bond
86836-81-9
|
Polofil Molar
131553-62-3
|
ESPE Visio-Gem
109676-12-2
|
[2-(Pyridine-2-yl)-2-propanato]iridium(IV) dimer solution 97% (1 mM in 0.1 Molar aqueous NaIO3)
1446713-81-0
|
Polyglyceryl-2 Dioleate
60219-68-3
|
galden (tm) ht70
69991-67-9
|
1-(4-chlorophenyl)-3-(2-(3,4-dihydroisoquinolin-2(1H)-yl)-2-oxoethyl)imidazolidin-2-one
1323297-45-5
|
1,4-Dimethyl-3-(o-tolyl)-1h-pyrazol-5-amine
1152654-87-9
|
N-((1-((2,5-dimethylfuran-3-yl)methyl)piperidin-4-yl)methyl)pyrazine-2-carboxamide
1235089-88-9
|
N-((1-((2,5-dimethylfuran-3-yl)methyl)piperidin-4-yl)methyl)-5-methylisoxazole-3-carboxamide
1235342-25-2
|
N-(3-methoxyphenethyl)-2-(3-methyl-6-oxopyridazin-1(6H)-yl)propanamide
1234868-86-0
|
N-(1H-benzo[d]imidazol-2-yl)-2-(3-methyl-6-oxopyridazin-1(6H)-yl)propanamide
1234949-55-3
|
2-(3-methyl-6-oxopyridazin-1(6H)-yl)-N-(2-phenoxyethyl)propanamide
1235377-68-0
|
6-methyl-2-(1-oxo-1-(4-phenylpiperazin-1-yl)propan-2-yl)pyridazin-3(2H)-one
1235665-35-6
|
Dibenz[c,h]acridinium, 14-(4-ethoxy-4-oxobutyl)-5,6,8,9-tetrahydro-7-phenyl-, 1,1,1-trifluoromethanesulfonate (1:1)
457602-08-3
|
N-(2-(1H-indol-3-yl)ethyl)-2-(3-methyl-6-oxopyridazin-1(6H)-yl)propanamide
1234885-72-3
|
